Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07482618
Evaluation of Spasticity, Neuropathic Pain, and Gait Analysis in Stroke Patients Receiving Tolperison Therapy After Botulinum Toxin Injection
Sponsor: Ayse Guc
View on ClinicalTrials.gov
Summary
Tolperison is an antispastic agent used in the treatment of spasticity. Studies on tolperison are limited, and the literature on its effectiveness against spasticity and neuropathic pain is also limited.
Official title: Evaluation of Spasticity, Neuropathic Pain, and Gait Analysis in Stroke Patients Receiving Tolperison Therapy After Botulinum Toxin Injection: A Controlled Study
Key Details
Gender
All
Age Range
18 Months - 80 Months
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-08-13
Completion Date
2026-07-10
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Locations (1)
Kayseri City Hospital Physical Medicine and Rehabilitation
Kayseri, Kocasinan, Turkey (Türkiye)